A. Theriault et Pr. Cohen, HERPETIC GEOMETRIC GLOSSITIS IN A PEDIATRIC-PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA, American journal of clinical oncology, 20(6), 1997, pp. 567-568
Herpetic geometric glossitis, a recently described form of lingual her
pes simplex virus type 1 (HSV-1) infection, has been reported in 6 hum
an immunodeficiency virus (HIV) patients and 1 cardiac transplant pati
ent who was receiving immunosuppressant therapy. An HIV-seronegative i
mmunocompromised pediatric patient with acute myelogenous leukemia who
developed herpetic geometric glossitis is described. Herpetic geometr
ic glossitis can present in both adult and pediatric immunocompromised
patients. The symptoms, morphology, laboratory findings and treatment
of this infection are summarized. The possible consequences of untrea
ted herpetic glossitis include superinfection and undernourishment. Al
though previously described patients responded to 1000 mg per day (div
ided in 5 doses) of oral acyclovir, with complete resolution of fissur
es, this patient developed herpetic geometric glossitis while receivin
g acyclovir and required higher doses of oral antiviral therapy (acycl
ovir, 3000 mg/day divided in 5 doses) to treat his HSV-1 lingual infec
tion. Empiric treatment of an immunocompromised patient who has newly
acquired painful tongue fissures or furrows with systemic acyclovir sh
ould be considered.